About Affera
Affera is a Healthcare company based in Boston (United States) founded in 2014, and was acquired by Medtronic in January 2022. Devices for treating heart rhythm disorders are developed. The company has 30 employees. Affera offers products and services including Lattice-Tip Focal Catheter and Mapping and Ablation System. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is AFFERA, INC. Its competitors include Adagio Medical, Farapulse and Field Medical; 3 of its 3 listed competitors have raised funding.
Company details
Affera was founded in 2014 and is headquartered in Boston, United States. Medical devices focused on cardiology are developed by the company, with an emphasis on an integrated platform for delivering therapy to patients with cardiac arrhythmias. Operations center on creating durable solutions for a range of arrhythmia cases. Key products include the SpherePVI and Sphere9 catheters, aimed at improving treatment efficiency in the sector.
- Headquarters Boston, United States
- Employees 30
- Stage Acquired
- SectorsHealthcare
- Website affera.com
- Acquired by Medtronic (Jan 2022)
- Legal Name Affera, Inc.
Products & Services of Affera
Affera offers a comprehensive portfolio of products and services, including Lattice-Tip Focal Catheter and Mapping and Ablation System.
Catheter for radiofrequency and pulsed field ablation of arrhythmias.
Integrated system for efficient arrhythmia therapy and lesion durability.
Funding Insights of Affera
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Affera with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2021 | Seed | – | Innogest Capital | – |
2 investors in total: 2 institutional.
Investors in Affera
Affera has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Medtronic and Innogest Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
VC firm investing in seed and early stage companies in Italy | innogestcapital.com | Milan, Italy | ||
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | medtronic.com | Minneapolis, United States |
Investor details for Affera
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Affera
2 people are tracked at Affera (1 in leadership, 1 in team); the tracked headcount is 30.
| Name | Role | Group |
|---|---|---|
Michael Wexler | Cfo/coo | Leadership |
Yanko Sheiretov | Principal Engineer | Team |
Complete people profiles for Affera
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Affera
3 dated milestones of Affera across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Affera is founded.
- Funding First funding round.
- Exit Acquired by Medtronic.
Competitors of Affera
Affera has 3 listed competitors in our database, 3 of them funded. They include Adagio Medical, Farapulse and Field Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| adagiomedical.com | 2011 | Laguna Hills, United States | $72.14M | 72 | Cardiovascular therapies are developed by Adagio Medical in stealth mode. | |
| farapulse.com | 2014 | Menlo Park, United States | $36.3M | Devices for cardiac ablation via pulsed field technology are developed. | ||
| fieldmedicalinc.com | 2022 | Encinitas, United States | $75M | Pulsed electric field ablation devices for heart arrhythmias are developed. |
Detailed competitors of Affera
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Affera
The website of Affera (affera.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▼ 22.8% vs previous month
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Affera (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Affera
Complete news archive for Affera
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Affera
Affera was founded in 2014 and raised its 1st funding round 7 years after it was founded.
Affera is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Affera has 30 employees.
Affera was founded in 2014 and is headquartered in Boston, United States. Medical devices focused on cardiology are developed by the company, with an emphasis on an integrated platform for delivering therapy to patients with cardiac arrhythmias. Operations center on creating durable solutions for a range of arrhythmia cases. Key products include the SpherePVI and Sphere9 catheters, aimed at improving treatment efficiency in the sector.
Affera's top competitors include Adagio Medical, Field Medical and Farapulse.
Affera offers Lattice-Tip Focal Catheter and Mapping and Ablation System.
Affera has 2 investors. Key investors include Medtronic, and Innogest Capital.
Affera operates through Affera, Inc..
Yes. Affera was acquired by Medtronic in January 2022.